tiprankstipranks
Blurbs

Analysts Conflicted on These Services Names: McDonald’s (MCD), Waste Management (WM) and Medpace Holdings (MEDP)

Analysts have been eager to weigh in on the Services sector with new ratings on McDonald’s (MCDResearch Report), Waste Management (WMResearch Report) and Medpace Holdings (MEDPResearch Report).

McDonald’s (MCD)

In a report issued on July 26, David Tarantino from Robert W. Baird maintained a Buy rating on McDonald’s, with a price target of $285.00. The company’s shares closed last Thursday at $263.46, close to its 52-week high of $271.15.

According to TipRanks.com, Tarantino is a 5-star analyst with an average return of 7.2% and a 60.7% success rate. Tarantino covers the Services sector, focusing on stocks such as Restaurant Brands International, Cheesecake Factory, and BJ’s Restaurants.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for McDonald’s with a $281.27 average price target, representing an 8.7% upside. In a report issued on July 27, Barclays also maintained a Buy rating on the stock with a $285.00 price target.

See today’s best-performing stocks on TipRanks >>

Waste Management (WM)

In a report issued on July 27, David Manthey from Robert W. Baird maintained a Hold rating on Waste Management, with a price target of $166.00. The company’s shares closed last Thursday at $164.57.

According to TipRanks.com, Manthey is a 5-star analyst with an average return of 9.9% and a 61.7% success rate. Manthey covers the Industrial Goods sector, focusing on stocks such as SiteOne Landscape Supply, Beacon Roofing Supply, and Wesco International.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Waste Management with a $171.44 average price target, implying a 7.1% upside from current levels. In a report issued on July 19, RBC Capital also maintained a Hold rating on the stock with a $162.00 price target.

Medpace Holdings (MEDP)

In a report issued on July 26, Eric Coldwell from Robert W. Baird maintained a Hold rating on Medpace Holdings, with a price target of $145.00. The company’s shares closed last Thursday at $165.90.

According to TipRanks.com, Coldwell is a 5-star analyst with an average return of 9.3% and a 54.4% success rate. Coldwell covers the Healthcare sector, focusing on stocks such as AmerisourceBergen, Quest Diagnostics, and Cardinal Health.

Medpace Holdings has an analyst consensus of Hold, with a price target consensus of $147.00, implying a -9.5% downside from current levels. In a report issued on July 11, Jefferies also maintained a Hold rating on the stock with a $143.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MCD:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More